News
Federation of Clinical Immunology Societies Awards Five Benaroya Research Institute Scientists
Read More
Press Release
Benaroya Research Institute Appoints New Principal Investigator Allyson Byrd, PhD
Read More
Press Release
IgA Autoantibodies Synergize With IgG To Increase Inflammatory Responses in Lupus
Read More
Press Release
New Study in Nature Communications From Benaroya Research Institute Finds Islet Antigen Reactive TCR Alpha Chains are Shared Between Blood and Pancreas T Cells
Read More
External News
BRI’s John Ray, PhD, Receives Lupus Research Alliance Lupus Innovation Award
Read More ➡
Press Release
A Subset of Expanded Regulatory T Cells Is Linked With C-Peptide Preservation in Children With New Onset Type 1 Diabetes
Read More
Press Release
A Novel Approach To Identify and Investigate B Cells Specific to Gut Microbes
Read More
Press Release
Benaroya Research Institute Awarded $4.1 Million National Institutes of Health Grant to Study Regulatory T Cells’ Function in Immune System Homeostasis
Read More
Press Release
Runner Completes “2 Half Marathons, 2 Coasts, 2 Days” in support of BRI and Autoimmune Disease Awareness
Read More
External News
LITAF Protects Against Pore-Forming Protein–Induced Cell Death by Promoting Membrane Repair: Interview with Drs. Stefani & Lacy-Hulbert
Read More ➡
Press Release
Benaroya Research Institute’s Steven F. Ziegler, PhD, Named 2024 Distinguished Fellow by the American Association of Immunologists
Read More
Press Release
Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research
Read More
Press Release
Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death
Read More
External News
Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Read the publication ➡
Press Release
